Prehypertension Clinical Trial
Official title:
Examining Factors Influencing Adherence to and Efficacy of a Wholegrains and Nuts Intervention to Reduce Blood Pressure in Prehypertension: a Series of N-of-1 Interventional Studies
The aim of the study is to investigate whether physiological, psychological and environmental factors, at an individual level, modify a) adherence, and b) blood pressure response, to a nuts and wholegrains intervention in participants at risk for developing high blood pressure. For 24 weeks, participants will, on a daily basis, monitor their own blood pressure using a wireless blood pressure monitor and respond to short semi-personalised questionnaires using a wrist-worn device, which also measures activity levels. Participants will receive an intervention of wholegrain foods and nuts to substitute into their diets for 8 weeks, between two 8-week observation periods. The length of the study periods will enable repeated measurements to be taken, in order to assess what factors, on an individual level, are associated with fluctuations in the outcomes. This will provide an insight into the types of factors that can help to explain individual fluctuations in adherence and physiological outcomes, such as blood pressure, that are common in nutrition studies. In the future, this should help in tailoring the way the investigators deliver effective individualised interventions, and enable researchers to be better able to consider and control for factors that can affect adherence and response to dietary interventions.
The study will be conducted as an interventional N-of-1 study with an A1-B-A2 design of 8 weeks per study period. Prior to the study, participants will be screened and if eligible, will complete a number of baseline questionnaires to provide an overview of their typical eating and lifestyle-related behaviours, and general health. A second visit prior to the start of the study will then be arranged, where participants will undergo a semi-structured interview. Responses from the interview, in combination with their baseline questionnaire responses, will be used to identify factors specific to the participant that show some degree of variability. These will form the basis of the semi-personalised questionnaires delivered via the wrist-worn PRO-Diary device for the duration of the study. During the study, participants will visit the institute in a fasted state every 4 weeks (7 visits total), in order to provide a blood sample for assessment of cholesterol levels and for assessment of biomarkers of wholegrains intake. At the first visit, participants will receive the wireless blood pressure monitor and PRO-Diary wrist device programmed with twice-daily questionnaires at times convenient to the participant. After 2 weeks and every 4 weeks thereafter, participants will be sent a link by email to complete a 24-hour dietary recall. After 8 weeks, participants will begin the intervention phase and receive wholegrains equivalent to 3 portions a day and 1 portion of unsalted nuts per day for the following 8 weeks. Participants will be able to choose from a variety of wholegrain products commonly available at supermarkets. They will also receive dietary advice to follow a Dietary Approaches to Stop Hypertension (DASH) diet aimed at lowering blood pressure. All other measures will continue as previously. At week 16, the wholegrains and nuts will be withdrawn and participants will be followed up for a further 8 weeks. At their final visit to the institute, they will complete the same validated questionnaires as at baseline. Results from the study will be analysed using N-of-1 dynamic modelling to analyse trends over time and determine whether any personalised factors significantly affected adherence to intervention or blood pressure response. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Completed |
NCT02551640 -
Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients
|
N/A | |
Recruiting |
NCT01483430 -
Effect of Ginseol Kg1 on Blood Pressure Lowering
|
Phase 3 | |
Completed |
NCT01637909 -
Korean Life-Style Modification Effects on Blood Pressure
|
N/A | |
Terminated |
NCT01295216 -
Use of Mobile Technology to Prevent Progression of Pre-hypertension in Latin American Urban Settings
|
N/A | |
Unknown status |
NCT01308983 -
Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension
|
Phase 4 | |
Active, not recruiting |
NCT03596099 -
Rice Vinegar as an Intervention to Lower Blood Pressure in Adults With Prehypertension and 10-year CVD Risk <10%
|
N/A | |
Completed |
NCT03898518 -
The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls
|
N/A | |
Terminated |
NCT01983462 -
Vascular Dysfunction in Human Obesity Hypertension
|
Phase 2 | |
Completed |
NCT01458496 -
Health Coaching to Effect Lifestyle Behaviour Change
|
N/A | |
Completed |
NCT01472692 -
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
|
Phase 4 | |
Completed |
NCT03266510 -
Inspiratory Muscle Strength Training to Improve Blood Pressure and Physiological Function
|
N/A | |
Completed |
NCT02998840 -
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
|
Phase 2 | |
Completed |
NCT01974570 -
Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects
|
Phase 2 | |
Completed |
NCT02326766 -
Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects
|
Phase 3 | |
Completed |
NCT01395329 -
Nebivolol and the Endothelin (ET)-1 System
|
Phase 4 | |
Completed |
NCT01331486 -
Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract
|
Phase 1 | |
Completed |
NCT05274971 -
Diet and Exercise on Ambulatory Blood Pressure
|
N/A | |
Active, not recruiting |
NCT02371317 -
Stress Management for High Blood Pressure
|
N/A | |
Completed |
NCT03006471 -
Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension
|
Phase 4 |